Markets:

Overview

News

Currencies

International

Treasuries

BioLineRx Ltd. - American Depositary Shares (NQ:BLRX)

3.350 -0.130 (-3.74%)

Streaming Delayed Price Updated: 3:17 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioLineRx Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Nasdaq Surges Over 300 Points; State Street Earnings Top Views ↗

January 17, 2025

Via Benzinga

S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings ↗

January 17, 2025

Via Benzinga

Topics Stocks

Dow Jumps Over 300 Points; US Industrial Production Beats Estimates ↗

January 17, 2025

Via Benzinga

Topics Stocks

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗

January 16, 2025

Via Benzinga

Earnings Preview For BioLine Rx ↗

November 22, 2024

Via Benzinga

BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024 ↗

August 15, 2024

BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024.

Via InvestorPlace

Earnings Preview For BioLine Rx ↗

March 25, 2024

Via Benzinga

BioLine Rx Earnings Preview ↗

November 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 06, 2025

Via Benzinga

Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet ↗

January 06, 2025

Via Benzinga

S&P Jumps 1%; Regional Health Properties Shares Spike Higher ↗

January 06, 2025

Via Benzinga

Topics Stocks

US Stocks Open Higher; Dow Jumps Over 200 Points ↗

January 06, 2025

Via Benzinga

Topics Stocks

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket ↗

January 03, 2025

Via Benzinga

Earnings Scheduled For November 25, 2024 ↗

November 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 11, 2024

Via Benzinga

Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket ↗

October 07, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 18, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!

Via InvestorPlace

Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 ↗

June 05, 2024

These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.

Via InvestorPlace

BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024 ↗

May 28, 2024

BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023 ↗

March 26, 2024

BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 26, 2024

Via Benzinga

Earnings Scheduled For March 26, 2024 ↗

March 26, 2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.

Via Benzinga

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth

March 06, 2024

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

Via FinancialNewsMedia

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond ↗

February 25, 2024

When you want to light your afterburners, these ideas will do the trick.

Via InvestorPlace

Earnings Scheduled For November 20, 2023 ↗

November 20, 2023

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.

Via Benzinga

Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion ↗

November 04, 2023

Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have...

Via Talk Markets

3 Tech Stocks That Wall Street Loves More Than Nvidia ↗

November 02, 2023

Purchase these top tech stocks now to achieve maximum profits and allow your portfolio to skyrocket given the volatile market.

Via InvestorPlace

3 Top Penny Stocks to Make You a Millionaire in 5 Years ↗

October 30, 2023

Penny stocks can make you a millionaire with patience and luck especially when you follow secular trends overall.

Via InvestorPlace

BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer ↗

September 28, 2023

BioLineRx Ltd (NASDAQ: BLRX) announced data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial of motixafortide and gemcitabine and nab-paclitaxel...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.